LivaNova PLC Livanova Plc: Transaction In Own Shares

 
TIDMLIVN 
 
 
   21 October 2016 
 
   TRANSACTION IN OWN SHARES 
 
   LivaNova PLC (the "Company" or "LivaNova") announces on 21 October 2016, 
the repurchase of 11,200 ordinary shares on 20 October 2016 as a part of 
the US $150 million share repurchase programme previously announced on 2 
August 2016.  The highest price paid per ordinary share was $56.61 and 
the lowest price paid per share was $55.94.  The repurchased shares will 
be cancelled.  As of 20 October 2016, after giving effect to the 
cancellation of these ordinary shares, the number of shares of ordinary 
shares outstanding would be 48,785,869, and the total number of voting 
rights in the Company would be 48,785,869, which may be used by 
shareholders as the denominator for the calculations by which they will 
determine if they are required to notify their interest in, or a change 
to their interest in the Company under the FCA's Disclosure Guidance and 
Transparency Rules. 
 
   The above purchases were made by Merrill Lynch, Pierce, Fenner & Smith 
Incorporated. 
 
   About LivaNova 
 
   LivaNova PLC is a global medical technology company formed by the merger 
of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, 
and Cyberonics Inc., a medical device company with core expertise in 
neuromodulation.  LivaNova transforms medical innovation into meaningful 
solutions for the benefit of patients, healthcare professionals, and 
healthcare systems.  The Company employs approximately 4,600 employees 
worldwide and is headquartered in London, U.K.  With a presence in more 
than 100 countries, LivaNova operates as three business units: Cardiac 
Surgery, Cardiac Rhythm Management, and Neuromodulation, with operating 
headquarters in Clamart (France), Mirandola (Italy) and Houston (U.S.), 
respectively. 
 
   LivaNova is listed on NASDAQ and listed on the Official List of the UK's 
Financial Conduct Authority and traded on London Stock Exchange (LSE) 
under the ticker symbol "LIVN". 
 
   For more information, please visit www.livanova.com, or contact: 
 
   Investor Relations and Media 
 
   Karen King 
 
   Vice President, Investor Relations & Corporate Communications 
 
   Phone: [phone] 
 
   Fax: [phone] 
 
   e-mail: [e-mail] 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: LivaNova PLC via Globenewswire 
 
 
 
 

(END) Dow Jones Newswires

October 21, 2016 02:00 ET (06:00 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.